Parexel International Corporation, a contract research organization, has agreed to acquire Health Advances, LLC, an independent life sciences strategy consulting firm. Health Advances combines clinical, scientific and business expertise to provide strategic advice to executives leading life sciences companies and investors. The acquisition is expected to close in February, subject to the satisfaction of closing conditions including expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.

Established in 1992, Health Advances employs approximately 120 scientists, clinicians, and business professionals in three main offices: two in the US and one in Europe. It offers specialized services such as portfolio planning, product positioning, market assessment and forecasting, strategic and business planning, as well as advising on partnering and acquisitions.

Source: Parexel